Cavernous angioma surgery: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
|||
| Line 30: | Line 30: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Needs | [[Category:Needs english review]] | ||
Revision as of 19:06, 22 March 2022
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma surgery On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma surgery |
|
Risk calculators and risk factors for Cavernous angioma surgery |
Overview
Surgery is the mainstay treatment for cavernous angioma. Complete surgical resection should be done to prevent seizures and hemorrhage due to remnant tissue.
Indication
Surgery
- Surgical resection is the most preferred interventionfor cavernous angioma.
- Complete resection is needed as remnant tissue can cause high risk of seizure and hemorrhage.[1]
- Factors that complicate procedure include:
- Presence of gliosis
- Calcification
- Hyaline degeneration [2]
- If seizure surgery occurs, hemosiderin ring should be removed.[3]
References
- ↑ Stapleton CJ, Barker FG (2018). "Cranial Cavernous Malformations: Natural History and Treatment". Stroke. 49 (4): 1029–1035. doi:10.1161/STROKEAHA.117.017074. PMID 29535273.
- ↑ Wang CC, Liu A, Zhang JT, Sun B, Zhao YL (2003). "Surgical management of brain-stem cavernous malformations: report of 137 cases". Surg Neurol. 59 (6): 444–54, discussion 454. doi:10.1016/s0090-3019(03)00187-3. PMID 12826334.
- ↑ Cenzato M, Stefini R, Ambrosi C, Giovanelli M (2008). "Post-operative remnants of brainstem cavernomas: incidence, risk factors and management". Acta Neurochir (Wien). 150 (9): 879–86, discussion 887. doi:10.1007/s00701-008-0008-4. PMID 18754072.